Fontolizumab in moderate to severe Crohn's disease: A phase 2, randomized, double‐blind, placebo‐controlled, multiple‐dose study
暂无分享,去创建一个
P. Rutgeerts | D. Hommes | C. Bernstein | B. Sands | W. Reinisch | B. Feagan | S. Katz | T. Pearce | D. Riff | I. Rácz | A. Cortot | I. Altorjay | M. Cheng | Michael Gaspari | L. Simon | L. Bene | W. de Villiers